The CDC's Morbidity and Mortality Weekly Report ( MMWR) resumed publishing after an unprecedented 2-week hiatus, but without the three H5N1 avian influenza papers that were slated to publish on Jan.
DALLAS - Mangoceuticals, Inc. (NASDAQ: MGRX), a telemedicine company focused on men's wellness products with a market capitalization of $8.12 million, has announced progress in its H1N1 efficacy study ...
Some results have been hidden because they may be inaccessible to you